Comerica Bank
RAPT

Comerica Bank’s RAPT Therapeutics RAPT Stock Holding History

Comerica Bank’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,166
Closed -$109K – 3783
2025
Q1 		$109K Buy
11,166
+3,911
+54% +$38.5K ﹤0.01% 2548
2024
Q4 		$91.7K Buy
+7,255
New +$92.2K ﹤0.01% 2629
2024
Q2 		– Sell
-28
Closed -$1.99K – 3794
2024
Q1 		$1.99K Hold
28
– – ﹤0.01% 3535
2023
Q4 		$5.54K Buy
28
+3
+12% +$371 ﹤0.01% 3290
2023
Q3 		$3.32K Buy
+25
New +$4.08K ﹤0.01% 3467

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Comerica Bank's RAPT Position: Q2 2025 in Review

Comerica Bank sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 11,166 shares — an estimated $109K sold.

Comerica Bank first reported a position in RAPT in Q3 2023 and held it in 5 quarters. The position peaked at $109K in Q1 2025. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Comerica Bank reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 11,166 RAPT Therapeutics shares in Q2 2025, an estimated $109K.
  • Comerica Bank first reported a position in RAPT Therapeutics in Q3 2023 and held it in 5 quarters.
  • Comerica Bank's RAPT Therapeutics position peaked at $109K in Q1 2025.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.